Company page

Mesoblast Limited

Mesoblast Limited is a public company listed on the Australian market under the ticker MSB, with a market capitalization of approximately AUD 1.8 billion. The company focuses on developing innovative cellular therapies for various medical conditions. Mesoblast aims to address significant unmet medical needs through its advanced research and development efforts.